Strs Ohio Cyma Bay Therapeutics, Inc. Transaction History

Strs Ohio

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 26, 2023	SELL	$10.86 - $17.62 $31,494 - $51,098	-2,900 Reduced 23.58%	9,400 $140,000
Q2 2023 Jul 31, 2023	BUY	$7.47 - $10.95 $91,881 - $134,685	12,300 New	12,300 $134,000
Q2 2021 Jul 26, 2021	SELL	$3.94 - $4.92 $31,914 - $39,852	-8,100 Closed	0 $0
Q1 2021 Apr 23, 2021	SELL	$4.23 - $6.55 $178,929 - $277,065	-42,300 Reduced 83.93%	8,100 $36,000
Q4 2020 Jan 25, 2021	BUY	$5.73 - $9.03 $254,412 - $400,932	44,400 Added 740.0%	50,400 $289,000

Q3 2020 Dec 14, 2020	BUY	$3.32 - $7.24 $19,920 - $43,440	6,000 New	6,000 $43,000
Q4 2018 Jan 23, 2019	SELL	$6.54 - $11.74 $0 - $0	0 Closed	0 $0
Q3 2018 Oct 19, 2018	SELL	$10.88 - $14.52 $187,136 - $249,744	-17,200 Closed	0 $0
Q2 2018 Aug 06, 2018	BUY	$10.66 - $14.38 $183,352 - $247,336	17,200 New	17,200 $230,000

1.88M

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.